In China, some of us are keeping elderly care in the family – for now

AI Summary
In China, a family is managing the care of their 90-year-old grandmother, who lives in northern China and suffers from lung cancer, stroke, and Alzheimer's disease. The grandmother's adult children share the responsibility of her daily medication and care. Initially, the cost of her lung cancer medication was a significant financial burden, but in 2018, the inclusion of drugs like gefitinib in China’s medical insurance catalogue made treatment more accessible. As China's population ages, with 22% being 60 or older in 2024, the country is implementing plans to improve dementia prevention and care by 2030. This family's experience reflects broader challenges and changes in elderly care within China.
Article Analysis
Key Claims (5)
AI-ExtractedAn action plan is being implemented to build a comprehensive dementia prevention and care system by 2030.
As of 2024, 310 million people or 22 per cent are 60 and older in China.
The catalogue covers more than 230 anticancer drugs.
In 2018, drugs like gefitinib were included in China’s medical insurance catalogue.
One pill to be taken daily used to cost about 500 yuan.
Key Entities & Roles
Keywords
Sentiment Analysis
Source Transparency
This article was automatically classified using rule-based analysis.
Topic Connections
Explore how the topics in this article connect to other news stories
Find Similar Articles
AI-PoweredDiscover articles with similar content using semantic similarity analysis.